Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Cancer treatment in the age of COVID-19 and the current worldwide impact
Prof Richard Sullivan - Kings College London, UK
Cancer treatment in the age of COVID-19 and the current worldwide impact ( Prof Richard Sullivan - Kings College London, UK )
24 Mar 2020
Over-diagnosis of low-grade prostate cancer, good or bad?
Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium
Over-diagnosis of low-grade prostate cancer, good or bad? ( Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium )
24 Feb 2020
India's strategy for the prevention of head and neck cancers and lung cancer
Dr Abhishek Shankar - Consultant Oncologist, AIIMS, New Delhi, India
India's strategy for the prevention of head and neck cancers and lung cancer ( Dr Abhishek Shankar - Consultant Oncologist, AIIMS, New Delhi, India )
20 Feb 2020
Community based cancer prevention and the contribution of the environment to can...
Dr Abhishek Shankar - Consultant Oncologist, AIIMS, New Delhi, India
Community based cancer prevention and the contribution of the environment to cancer ( Dr Abhishek Shankar - Consultant Oncologist, AIIMS, New Delhi, India )
20 Feb 2020
The importance of mentoring upcoming African oncologists
Dr Nwamaka Lasebikan - University of Nigeria Teaching Hospital, Enugu, Nigeria
The importance of mentoring upcoming African oncologists ( Dr Nwamaka Lasebikan - University of Nigeria Teaching Hospital, Enugu, Nigeria )
5 Feb 2020
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-pos...
Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer ( Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA )
23 Jan 2020
Could trastuzumab deruxtecan become the new standard of care for pretreated HER2...
Dr Ian Krop - Dana Farber Cancer Institute, Boston, USA
Could trastuzumab deruxtecan become the new standard of care for pretreated HER2-positive breast cancer patients? ( Dr Ian Krop - Dana Farber Cancer Institute, Boston, USA )
18 Dec 2019
Trastuzumab deruxtecan yields promising results in HER2-positive breast cancer p...
Dr Ian Krop - Dana Farber Cancer Institute, Boston, USA
Trastuzumab deruxtecan yields promising results in HER2-positive breast cancer patients pretreated with TDM-1 ( Dr Ian Krop - Dana Farber Cancer Institute, Boston, USA )
18 Dec 2019
Venetoclax chemo combo active and well-tolerated in children with r/r AML
Dr Seth Karol - St. Jude Children’s Research Hospital, Memphis, USA
Venetoclax chemo combo active and well-tolerated in children with r/r AML ( Dr Seth Karol - St. Jude Children’s Research Hospital, Memphis, USA )
12 Dec 2019
Advances in radiotherapy for elderly patients with prostate cancer
Dr Lucinda Morris - St George Hospital Cancer Care Centre, Sydney, Australia
Advances in radiotherapy for elderly patients with prostate cancer ( Dr Lucinda Morris - St George Hospital Cancer Care Centre, Sydney, Australia )
29 Nov 2019
The role of the pharmacist in supporting multi-disciplinary education
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
The role of the pharmacist in supporting multi-disciplinary education ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
KATHERINE trial updates for HER2-positive breast cancer
Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany
KATHERINE trial updates for HER2-positive breast cancer ( Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany )
7 Oct 2019